Digital transformation in pharma TEST

Others
Digital transformation in pharma TEST

Using AI to make a big impact for emerging and mid-sized biopharma companies

With recent market changes catalysing a rapid shift to an omnichannel approach, life science organisations of every size are racing to adapt their commercial approach to be more relevant, coordinated and personalised to the needs of each HCP.

Artificial intelligence (AI) tools hold the key to delivering intelligent engagement at scale - especially for mid-sized organisations and smaller markets with lean commercial and data science teams.

Join us to learn how Antares Pharma is working with Aktana Inc and Veeva Systems to rapidly implement an AI-driven omnichannel approach that delivers personalised campaigns to HCPs and a competitive advantage in a dynamic market.

Focus

This pharmaphorum webinar, held in association with Aktana, will take place on 29th April 2021 at 15:00 BST / 10:00 EDT and will also cover:

  • How AI, human insight and other advanced technologies can help life sciences teams optimise personalised omnichannel engagement with healthcare providers.
  • The best ways to engage with customers during COVID-19
  • How and why HCPs respond to specific tactics and strategies.

Our Panel
Matthew Van Wingerden - GM, Advanced Services, Aktana
Matthew Van Wingerden leads the Advanced Services team at Aktana, which focuses on leading customers through the exciting, but challenging, adoption of cutting edge AI technology.  Matthew brings a rigorous customer-centric approach to AI adoption from his five years of management consulting experience at McKinsey & Co. and a deeply technical scientific approach from his Chemistry PhD from Caltech. He supports Aktana's most advanced deployments, acting as a technical subject matter expert and helping customers transform complex analytical problems into tangible, impact-oriented business discussions.

Doug Caldwell - VP, Commercial Strategy, Veeva Systems
Doug is an accomplished executive with 20+ years of experience in the life sciences industry. As Vice President, Commercial Strategy at Veeva Systems he is a thought leader and trusted advisor to executives across the industry specializing in Commercial capabilities and technology enablement. He has expertise in the areas of end-to-end information management, business insight, and multichannel marketing with first-hand experience in technologies related to analytics, data warehousing, master data management, customer relationship management, and marketing automation.

Sal Paolozza - Senior Director of Sales Operations, Antares
Sal Paolozza is an experienced sales operations and business intelligence leader with 25+ years in the pharmaceutical industry. Sal is passionate about introducing sales technology innovations to improve sales processes and deliver actionable insights to sales and marketing teams. Prior to joining Antares Pharma as Senior Director of Sales Operations, he held various consulting and sales roles with IMS Health (now IQVIA) in the area of information management and business intelligence working with clients in the US and internationally.

Matthew Van Wingerden, GM, Aktana; Doug Caldwell, VP, Veeva Systems; Sal Paolozza, Director, Antares